Development and external validation of a composite biomarker-based machine learning model for sarcopenia risk stratification in patients with cardiovascular disease - Quiz - MDSpire

Development and external validation of a composite biomarker-based machine learning model for sarcopenia risk stratification in patients with cardiovascular disease

  • By

  • Pengcheng Mei

  • Tao Ying

  • Jing Wu

  • Han Wang

  • July 9, 2026

  • 0 min

Share

Original Source(s)

Development and external validation of a composite biomarker-based machine learning model for sarcopenia risk stratification in patients with cardiovascular disease

  • by Pengcheng Mei, Tao Ying, Jing Wu, Han Wang

  • July 9, 2026

Related Content

uFlowAM: an unsupervised framework for detection and visualization of abnormal intracardiac microflow on early-pregnancy fetal cardiac microflow imaging

Exploring the relationship between novel serum inflammatory markers, non-traditional lipid parameters, and in-stent restenosis after percutaneous coronary intervention: a single-center retrospective study

Sex-based disparities in cardiovascular outcomes: real-world evidence following chimeric antigen receptor T-cell therapy